<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There exists no pharmacological treatment for fulminating <z:hpo ids='HP_0002181'>brain edema</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Since evidence indicates that brain aquaporin-4 (AQP4) water channels are modulated by vasopressin V1a receptors, we examined the <z:hpo ids='HP_0000969'>edema</z:hpo>-reducing properties of the selective V1a receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, SR49059, following middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="2" pm="."><plain>Male Sprague-Dawley rats were randomly assigned to sham procedure, vehicle, or SR49059 infusion at different dosages (each n = 6,480 microL/hr, 640 microL/hr, 720 microL/hr) and starting 60 minutes before or after MCAO </plain></SENT>
<SENT sid="3" pm="."><plain>After a 2-hour period of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and 2 hours of reperfusion, the animals were sacrificed for assessment of brain water content, <z:chebi fb="199" ids="26708">sodium</z:chebi>, and <z:chebi fb="120" ids="26216">potassium</z:chebi> concentration </plain></SENT>
<SENT sid="4" pm="."><plain>Statistics were performed using an ANOVA followed by a Tukey post hoc analysis </plain></SENT>
<SENT sid="5" pm="."><plain>SR049059 treatment reduced brain water content in the infarcted area given at 640 microL/hr (p = 0.036), 720 microL/hr 60 minutes before (p = 0.002) or 60 minutes after (p = 0.005) MCAO </plain></SENT>
<SENT sid="6" pm="."><plain>The consecutive <z:chebi fb="199" ids="26708">sodium</z:chebi> shift into the brain was prevented (p = 0.001), while the <z:chebi fb="120" ids="26216">potassium</z:chebi> loss was inhibited only by pre-treatment (p = 0.003) </plain></SENT>
<SENT sid="7" pm="."><plain>These findings imply that in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced <z:hpo ids='HP_0002181'>brain edema</z:hpo>, the selective V1a receptor-<z:chebi fb="68" ids="48706">antagonist</z:chebi> SR49059 inhibits <z:hpo ids='HP_0002181'>brain edema</z:hpo> and the subsequent <z:chebi fb="199" ids="26708">sodium</z:chebi> shift into brain </plain></SENT>
<SENT sid="8" pm="."><plain>This substance offers a new avenue in <z:hpo ids='HP_0002181'>brain edema</z:hpo> treatment and prompts further study into AQP4 modulation </plain></SENT>
</text></document>